Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "United States Regenerative Medicine Market, Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
United States regenerative medicine market is expected to witness robust growth until 2026
The United States regenerative medicine market is driven by the growing popularity of stem cell-based therapies. Additionally, the use of regenerative medicines for treating chronic diseases, acute insults and maladies is further propelling the market in the country.
The United States regenerative medicine market is segmented based on type, material, application, company and region. Based on type, the market can be categorized into cell-based immunotherapy & cell therapy products, gene therapy products, tissue-engineered products and others.
The cell-based immunotherapy & cell therapy products segment is expected to dominate the market during forecast years on account of the growing demand for cell-based immunotherapies and establishment of cures act by FDA to streamline the regenerative medicine market. The segment has the most promising future on account of its capability to restore the lost function of tissues and organs.
Based on application, the market can be fragmented into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, dermatology and others. The dermatology application segment is expected to hold a significant market share during the forecast years. This can be attributed to the presence of easy grafting techniques for dermatological wounds and diseases.
Company Profiles: Detailed analysis of the major companies present in United States regenerative medicine market.
Major players operating in the United States regenerative medicine market include
Integra LifeSciences Holdings Corporation
Roche Diagnostics Corporation
Gilead Sciences, Inc
Astellas Pharma, Inc
bluebird bio, Inc
Medtronic USA, Inc
Organogenesis Holdings Inc
MiMedx Group Inc
Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022-2026
United States Regenerative Medicine Market, By Type:
Progenitor & Stem Cell Therapies
Tissue Engineered Products
United States Regenerative Medicine Market, By Material:
Biologically Derived Material
Genetically Engineered Material
United States Regenerative Medicine Market, By Application:
United States Regenerative Medicine Market, By Region:
For more information about this report visit https://www.researchandmarkets.com/r/a3695r
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900